Paper: Pulmonary delivery of siRNA targeting EGFR and PD-L1 in in vivo traceable NSCLC models
Rico Chi Hang Man is currently in the final year of his PhD study at The University of Hong Kong, HKSAR and King’s College London, UK. He graduated from Hong Kong Baptist University, HKSAR with a bachelor’s degree of Chemistry. He then obtained a master’s degree in Medical Sciences from The University of Hong Kong. After that, Rico started his PhD under the supervision of Dr. Jenny Lam and Dr. Gilbert Fruhwirth. His research interest focuses on the pulmonary delivery of small interfering RNA therapeutics for the treatment of non-small cell lung cancer.
During his PhD candidature, Rico was awarded the Pilot Scheme on International Experience for RPg Students for an oversea exchange in Dr. Gilbert Fruhwirth’s lab at King’s College London. In addition, Rico was awarded the second runner up in HKU Visualise Your Thesis Competition on his research project. Currently, Rico has published four scientific papers in peer-review journals such as Advanced Therapeutics, Journal of Controlled Release and Communications biology. He has presented an oral talk in European Molecular Imaging Meeting 2022, and this will be his first participation in DDL Conference for a poster presentation.